eLetters

151 e-Letters

published between 2009 and 2012

  • Registry study does not inform us abut management of ACS
    Brett Forge
    Chew et al claim that their registry study six month survival benefits associated with clinical guideline recommendations in acute coronary syndromes 1â₁“suggests that invasive management resulting in revascularisation does provide a reduction in mortality, reinforcing clinical trial data that have relied upon composite ischaemic end points that have at times been inconsistent".

    The very best that...

    Show More
  • Justification for complete revascularisation at the time of primary angioplasty? Not yet!
    Nick West

    We read with great interest the article by Politi et al. (1) on revascularisation of patients presenting with ST-elevation myocardial infarction (STEMI) in the context of multivessel coronary disease, and its accompanying Editorial. Whilst the data are interesting and hypothesis- generating, they fall short of demanding any change in current practice owing to a potential flaw in the study design and in the findings as pre...

    Show More
  • The case of the missing endpoints
    Michael Soljak

    Dear Editor

    The publication of not one but two reviews of catheter ablation for atrial fibrillation (AF) in this week's edition of Heart is very welcome.(1,2) The English and Welsh guidance from the National Institute for Clinical and Public Health Excellence (NICE) was published in 2006,(3) but a great deal of new comparative effectiveness evidence has been published recently. However there is a significant gap...

    Show More
  • Malfunction or malprogramming?
    Hoong Sern Lim

    Ullah and Stewart present a case of pacemaker-mediated tachycardia (PMT) and described it as a "malfunction of dual chamber pacing". However, I would contend that the pacemaker is functioning appropriately, ie: it is sensing atrial activity in the atrium and pacing (capturing) the ventricle. The problem in PMT is the retrograde atrial activation beyond the PVARP as described and appropriate programming of the PVARP based o...

    Show More
  • NICE guidance on the investigation of chest pain
    Andrew P. Davie

    Sir, As a "jobbing cardiologist", I am grateful for the NICE guidance on the investigation of stable chest pain. I am grateful for the emphasis on clinical assessment, and I am grateful for the shift away from exercise testing. I am astonished, however, that the guideline does not say one word about the utility of a therapeutic trial in cases of uncertainty, and nor does the editorial by Fox & McLean. Every cardiol...

    Show More
  • Prediction of risk; not all risk is mortality.
    Mamas A Mamas

    The recent editorial of Fox and Mclean concludes â₁“The NICE guidance on chest pain provides a series of important advances over the current status of investigation and triage of chest pain and should be welcomed by the profession 1. One of the key recommendations of the recently published National Institute for Health and Clinical excellence (NICE) guidelines for the early management of unstable...

    Show More
  • UNPLANNED REDUNDANT PUBLICATION. A CONSEQUENCE OF TOO MANY CARDIOVASCULAR JOURNALS?
    Magda Heras

    Dear editor,

    The avoidance of redundant publication is the core of the editorial task; therefore editors have established clear policies posted in their instructions for authors. The term Redundant publication has always been used for research reported by the same author and sent to two or more different journals. We report here a different situation that also results in unplanned redundant publication....

    Show More
  • Role of Myocardial Perfusion Imaging in Spontaneous Coronary Artery Dissection
    Arunkumar Panneerselvam

    To the Editor: I read with interest, the article by Christian J M Vrints (1) on spontaneous coronary artery dissection (SCAD). The images from current imaging modalities are impressive. The author has given an useful and practical approach to managing patients with SCAD.

    The author has recommended medical therapy for asymptomatic patients with SCAD, followed by computed tomogram on follow up. Myocardial perfu...

    Show More
  • Gender and Myocardial Infarctions
    Marina B Guerra

    Our ischaemic cardiopathy study group have read with interest the article written by Lawesson et al (1). First of all, the occurrence of ST-elevation myocardial infarction in young women is rare and the tobacco nocive role is well established in the medical literature. However, we would like to emphasize that smoking in women is growing nowadays. According to World Health Organization, there are 1,2 billion smokers around...

    Show More
  • Comments on a acute myocardial infarction study
    William C Tormen

    We have read with interest the article written by Bramlage et al (1) and we want to congratulate the authors and manifest our agreement with the findings of lower mortality in patients receiving optimal medical therapy (OMT) with statins, aspirin, clopidogrel, b-blockers, rennin angiotensin system blockers/ angiotensin-receptor blockers. However, we think appropriate to mention that patients who received OMT probably nee...

    Show More

Pages